Israeli precision medicine co DayTwo raises $37m
Israeli precision medicine co DayTwo raises $37m DayTwo uses AI, the sequencing of the gut microbiome and other clinical measures to create precision nutrition-based food prescriptions to balance blood sugar levels after meals. Israeli precision medicine company DayTwo has raised $37 million to continue development of technologies and solutions designed to improve the health of people with diabetes and other metabolic diseases. DayTwo’s existing investors participated in this latest financing round including aMoon of Marius Nacht and Dr. Yair Schindel, 10D of Yahal Zilka, and Cathay Innovat...